You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Sacral Neuromodulation
A sacral neuromodulator is an implantable device that generates gentle electrical impulses which are transmitted to an electrode, positioned close to the third sacral nerve.
The aim of this therapy is to restore communication between the brain and the bladder and/or between the brain and the digestive system, for the management of voiding and fecal disorders.1,2,3
Evaluation is a temporary phase designed to check whether the therapy works for the patient.
The goal is to improve quality of life and reduce symptoms, which corresponds to:
Will SNM work for you - (03:48)
Will SNM work for you
More information (see more)
Less information (see less)
In the test phase, an electrode is inserted into the lower back, close to the sacral nerves that control the bladder and bowel. At the end of the surgery, the lead is connected to an external and temporary stimulator which will stimulate the sacral nerves.
Before and during the test phase, patients will be asked to monitor their symptoms to check the effectiveness of the therapy.
At the end of the evaluation phase, the patient will meet with a member of the medical team to review the bladder diary, check whether symptoms have been reduced, and decide whether the therapy is suitable.
If the patient is not satisfied,
the electrode is removed and the treatment stops.
If the test has worked for the patient, a member of the team will see him/her to discuss how the neuromodulator will be implanted.
There are two different sacral neuromodulation systems: rechargeable and non-rechargeable.
The device best suited to the patient's needs will have been determined before the test phase with the medical team.
Regardless of the option chosen, the permanent sacral neuromodulation system consists of 2 components: an electrode and a neuromodulator. These components are implanted under the skin.
Sacral Neuromodulation Implementation Phase - (04:27)
Sacral Neuromodulation Implementation Phase
More information (see more)
Less information (see less)
The neuromodulator (which produces the electrical impulses for stimulation) will be placed beneath the surface of the skin, in the upper buttock and connected to the lead.
Many people don't feel the stimulation on a daily basis; if the therapy is working, this is perfectly normal. The goal is to achieve the most effective reduction of symptoms possible, without adverse effects, at minimal stimulation levels. An annual follow-up is recommended.
Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional.
Leng, W. W. & Chancellor, M. B. How sacral nerve stimulation neuromodulation works. Urol. Clin. North Am. 32, 11–8 (2005).
Chancellor, M. B. & Chartier-Kastler, E. J. Principles of Sacral Nerve Stimulation (SNS) for the Treatment of Bladder and Urethral Sphincter Dysfunctions. Neuromodulation Technol. Neural Interface 3, 16–26 (2000).
Gourcerol G. et al. How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis. 13(8):e203-11 (2011)